Navigation Links
Reminder: Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast
Date:8/4/2008

OMAHA, Neb., July 30 /PRNewswire-FirstCall/ -- Transgenomic Inc. (OTC Bulletin Board: TBIO.OB) announces the following Webcast:

What: Transgenomic Inc. Second Quarter 2008 Earnings Release

Conference Call

When: Wednesday, August 6, 2008 @ 8:30 a.m. Eastern

Where: http://www.transgenomic.com/events.asp?id=6

How: Live over the Internet -- Simply log on to the web at the

address above.

Contact: Investor Relations, 402-452-5400

To access the call via telephone, call 800-895-1085 or 785-424-1055. A replay of the call will be available via telephone until 11:59 pm ET on Wednesday, August 20, 2008. To access, dial 800-388-9064 or 402-220-1116.

About Transgenomic:

Transgenomic is a global biotechnology company that provides unique products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include WAVE(R) DHPLC Systems, related consumables and assay kits, cytogenetics automated systems, Transgenomic Molecular Clinical Reference Laboratory and Pharmacogenomics Research Services. Transgenomic's two laboratory services divisions utilize these technologies and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 validated diagnostic tests to meet the needs of pharmaceutical and biotech companies, research and clinical laboratories, physicians and patients. For more information about the innovative systems, products and services offered by Transgenomic, please visit: http://www.transgenomic.com.


'/>"/>
SOURCE Transgenomic Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. REMINDER: Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO
2. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
3. Reminder: XTL to Hold a Conference Call Today at 8:30 am EDT to Discuss the Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
4. Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast
5. Medivation Announces Second Quarter 2008 Teleconference and Webcast on August 11, 2008
6. deCODE genetics Announces Webcast of Conference Call to Discuss Second Quarter 2008 Financial Results
7. Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast
8. Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008
9. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
10. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Second Quarter 2008 Financial Results Call Set for August 5
11. Coherent, Inc. to Webcast Third Fiscal Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Malden, MA (PRWEB) , ... January 18, 2017 ... ... announced today that Dr. Dante Leven successfully implanted SpineFrontier’s A-CIFT™ Solofuse-P™. The operation ... Medical Center in Valley Stream, NY. The procedure was an anterior cervical discectomy ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... and paralysis, today announced that it has submitted a 510(k) to the FDA, ... that utilize MYOLYN’s patent-pending functional electrical stimulation (FES) technology. , The submission ...
(Date:1/18/2017)... Chicago, IL (PRWEB) , ... January 18, 2017 ... ... auction on January 24th, 2017, to sell research and genetic testing lab equipment ... of service in the Northwest and Northeast regions of the United States. This ...
(Date:1/18/2017)... Shareholder rights law firm Johnson & Weaver, ... members of CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD ... proposed sale of the Company to Eli Lilly and ... molecules for the acute treatment of migraines. ... a definitive merger agreement with Eli Lilly. Under the ...
Breaking Biology Technology:
(Date:1/18/2017)... 2017  In vitro diagnostic (IVD) companies were very ... (M&A), and Kalorama Information expects that trend to continue ... shifting. Generally, uncertainty in reimbursement and healthcare reform in ... changed the acquisitions landscape. Instead of looking to buy ... partners outside of their home country and also to ...
(Date:1/12/2017)... Jan. 12, 2017  New research undertaken by Fit ... the future.  1,000 participants were simply asked which office technology ... we may consider standard issue.  Insights on what will ... also gathered from futurists and industry leaders including Penelope ... Canton .  Some of these findings ...
(Date:1/6/2017)... Calif. , Jan. 6, 2017  Privately-held ... safety studies in healthy volunteers of a novel ... to treat acute pancreatitis. Acute ... typically a mild disorder, but can be very ... failure and sepsis, where extended hospital stays, time ...
Breaking Biology News(10 mins):